Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration

Nature Medicine

Volumn 19, Issue 6, 2013, Pages 695-703

  Lucas, Daniel ^a   Scheiermann, Christoph ^a,e   Chow, Andrew ^a,b   Kunisaki, Yuya ^a   Bruns, Ingmar ^a,c   Barrick, Colleen ^d   Tessarollo, Lino ^d   Frenette, Paul S ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d NATIONAL CANCER INSTITUTE   (United States)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 METHYLCATECHOL; NEURITE PROMOTING FACTOR;

ADRENERGIC NERVE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENE DELETION; GENOTOXICITY; HEMATOPOIETIC TISSUE; MOUSE; NERVE INJURY; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SENSORY NEUROPATHY; STEM CELL NICHE; SYMPATHETIC NERVE; SYMPATHETIC NERVE CELL; TISSUE REGENERATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE MARROW; CELL SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; RECEPTORS, ADRENERGIC, BETA; REGENERATION; SYMPATHETIC NERVOUS SYSTEM;

MUS;

EID: 84880301799     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3155     Document Type: Article

References (48)

1. Hooper, A.T. et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell 4, 263-274 (2009).
2. Banfi, A. et al. High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia. Cancer 92, 2419-2428 (2001).
3. Dominici, M. et al. Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation. Blood 114, 2333-2343 (2009).
4. Mauch, P. et al. Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 31, 1319-1339 (1995).
5. Haas, R. et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83, 3787-3794 (1994).
6. Tricot, G. et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 85, 588-596 (1995).
7. Robinson, S.N., Freedman, A.S., Neuberg, D.S., Nadler, L.M. & Mauch, P.M. Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation: CD34+, CD34+38-, and week-6 CAFC assays predict poor engraftment. Exp. Hematol. 28, 1325-1333 (2000).
8. Perseghin, P. et al. Management of poor peripheral blood stem cell mobilization: incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions. Transfus. Apher. Sci. 41, 33-37 (2009).
9. Noach, E.J. et al. Chemotherapy prior to autologous bone marrow transplantation impairs long-term engraftment in mice. Exp. Hematol. 31, 528-534 (2003).
10. Galotto, M. et al. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp. Hematol. 27, 1460-1466 (1999).
11. Kemp, K. et al. Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy. Ann. Hematol. 89, 701-713 (2010).
12. Méndez-Ferrer, S., Lucas, D., Battista, M. & Frenette, P.S. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 452, 442-447 (2008).
13. Méndez-Ferrer, S. et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829-834 (2010).
14. Cavaletti, G. & Marmiroli, P. Chemotherapy-induced peripheral neurotoxicity. Nat. Rev. Neurol. 6, 657-666 (2010).
15. Aloe, L., Manni, L., Properzi, F., De Santis, S. & Fiore, M. Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by cisplatin: behavioral, structural and biochemical analysis. Auton. Neurosci. 86, 84-93 (2000).
16. Katayama, Y. et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124, 407-421 (2006).
17. Yamazaki, S. et al. Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche. Cell 147, 1146-1158 (2011).
18. Lapidot, T., Dar, A. & Kollet, O. How do stem cells find their way home? Blood 106, 1901-1910 (2005).
19. Savitt, J.M., Jang, S.S., Mu, W., Dawson, V.L. & Dawson, T.M. Bcl-x is required for proper development of the mouse substantia nigra. J. Neurosci. 25, 6721-6728 (2005).
20. Buch, T. et al. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat. Methods 2, 419-426 (2005).
21. Spiegel, A. et al. Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling. Nat. Immunol. 8, 1123-1131 (2007).
22. Trimmer, P.A., Smith, T.S., Jung, A.B. & Bennett, J.P. Jr. Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity. Neurodegeneration 5, 233-239 (1996).
23. Marino, S., Vooijs, M., van Der Gulden, H., Jonkers, J. & Berns, A. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 14, 994-1004 (2000).
24. Kobayashi, H. et al. Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells. Nat. Cell Biol. 12, 1046-1056 (2010).
25. Ding, L., Saunders, T.L., Enikolopov, G. & Morrison, S.J. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481, 457-462 (2012).
26. Lévesque, J.P. et al. Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp. Hematol. 30, 440-449 (2002).
27. Schober, A. et al. Glial cell line-derived neurotrophic factor rescues target-deprived sympathetic spinal cord neurons but requires transforming growth factor-β as cofactor in vivo. J. Neurosci. 19, 2008-2015 (1999).
28. Saita, K. et al. A catechol derivative (4-methylcatechol) accelerates the recovery from experimental acrylamide-induced neuropathy. J. Pharmacol. Exp. Ther. 276, 231-237 (1996).
29. Callizot, N. et al. Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity. Cancer Chemother. Pharmacol. 62, 995-1007 (2008).
30. Smeyne, R.J. et al. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 368, 246-249 (1994).
31. Crowley, C. et al. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 76, 1001-1011 (1994).
32. Rezaee, F. et al. Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathway. PLoS ONE 5, e9690 (2010).
33. Coppola, V. et al. Ablation of TrkA function in the immune system causes B cell abnormalities. Development 131, 5185-5195 (2004).
34. Kiel, M.J., Yilmaz, O.H., Iwashita, T., Terhorst, C. & Morrison, S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121, 1109-1121 (2005).
35. Omatsu, Y. et al. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 33, 387-399 (2010).
36. Frenette, P.S., Pinho, S., Lucas, D. & Scheiermann, C. Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annu. Rev. Immunol. 31, 285-316 (2013).
37. Yamazaki, K. & Allen, T.D. Ultrastructural morphometric study of efferent nerve terminals on murine bone marrow stromal cells, and the recognition of a novel anatomical unit: the "neuro-reticular complex". Am. J. Anat. 187, 261-276 (1990).
38. Presley, C.A. et al. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy. Cell Commun. Adhes. 12, 307-317 (2005).
39. Armulik, A., Genove, G. & Betsholtz, C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 21, 193-215 (2011).
40. Franco, M., Roswall, P., Cortez, E., Hanahan, D. & Pietras, K. Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression. Blood 118, 2906-2917 (2011).
41. Windebank, A.J. & Grisold, W. Chemotherapy-induced neuropathy. J. Peripher. Nerv. Syst. 13, 27-46 (2008).
42. Chruscinski, A.J. et al. Targeted disruption of the β2 adrenergic receptor gene. J. Biol. Chem. 274, 16694-16700 (1999).
43. Mignone, J.L., Kukekov, V., Chiang, A.S., Steindler, D. & Enikolopov, G. Neural stem and progenitor cells in nestin-GFP transgenic mice. J. Comp. Neurol. 469, 311-324 (2004).
44. Lucas, D., Battista, M., Shi, P.A., Isola, L. & Frenette, P.S. Mobilized hematopoietic stem cell yield depends on species-specific circadian timing. Cell Stem Cell 3, 364-366 (2008).
45. Kamei, J., Nozaki, C. & Saitoh, A. Effect of mexiletine on vincristine-induced painful neuropathy in mice. Eur. J. Pharmacol. 536, 123-127 (2006).
46. Miller, C.L., Dykstra, B. & Eaves, C.J. Characterization of mouse hematopoietic stem and progenitor cells. Curr. Protoc. Immunol. 80, 22B.2 (2008).
47. Yuan, R., Astle, C.M., Chen, J. & Harrison, D.E. Genetic regulation of hematopoietic stem cell exhaustion during development and growth. Exp. Hematol. 33, 243-250 (2005).
48. Chow, A. et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J. Exp. Med. 208, 261-271 (2011).